PubMed

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.

Sternberg CN, Petrylak DP, Sartor O, Witjes JA, Demkow T, Ferrero JM, Eymard JC, Falcon S, Calabrò F, James N, Bodrogi I, Harper P, Wirth M, Berry W, Petrone ME, McKearn TJ, Noursalehi M, George M, Rozencweig M.

J Clin Oncol. 2009 Nov 10;27(32):5431-8. Epub 2009 Oct 5.PMID: 19805692 [PubMed - in process]Related articles

[Cancer therapy--economic aspects]

Catane R, Catane H, Rozencweig M.

Harefuah. 1995 Feb 1;128(3):182-5. Review. Hebrew. No abstract available. PMID: 7759013 [PubMed - indexed for MEDLINE]Related articles

Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virus.

McLaren C, Rozencweig M, Beltangady M, Nicaise C, Yarchoan R, Dolin R, Allan JD, Cooley TP, Seidlin M, Smaldone LF.

Clin Infect Dis. 1993 Feb;16 Suppl 1:S32-9.PMID: 8425018 [PubMed - indexed for MEDLINE]Related articles

Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complex.

Beltangady M, Knupp CA, Gustafson N, Barbhaiya RH, Dolin R, Seidlin M, Cooley TP, Rozencweig M.

Clin Infect Dis. 1993 Feb;16 Suppl 1:S26-31.PMID: 8093845 [PubMed - indexed for MEDLINE]Related articles

Overview of Taxol safety.

Onetto N, Canetta R, Winograd B, Catane R, Dougan M, Grechko J, Burroughs J, Rozencweig M.

J Natl Cancer Inst Monogr. 1993;(15):131-9. Review.PMID: 7912519 [PubMed - indexed for MEDLINE]Related articles

Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease.

Schacter LP, Rozencweig M, Beltangady M, Allan JD, Canetta R, Cooley TP, Dolin R, Kelley S, Lambert J, Liebman HA, et al.

Blood. 1992 Dec 15;80(12):2969-76.PMID: 1467512 [PubMed - indexed for MEDLINE]Related articlesFree article

Drug discovery and development in the pharmaceutical industry.

Schacter LP, Anderson C, Canetta RM, Kelley S, Nicaise C, Onetto N, Rozencweig M, Smaldone L, Winograd B.

Semin Oncol. 1992 Dec;19(6):613-21. Review.PMID: 1462163 [PubMed - indexed for MEDLINE]Related articles

Overview of hormonal therapy in advanced breast cancer.

Schacter LP, Rozencweig M, Canetta R, Kelley S, Nicaise C, Smaldone L.

Semin Oncol. 1990 Dec;17(6 Suppl 9):38-46.PMID: 2148026 [PubMed - indexed for MEDLINE]Related articles

Phase II study of tallysomycin S10b in patients with advanced head and neck cancer.

Nicaise C, Hong WK, Dimery W, Usakewicz J, Rozencweig M, Krakoff I.

Invest New Drugs. 1990 Aug;8(3):325-8.PMID: 1703132 [PubMed - indexed for MEDLINE]Related articles

Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients.

Rozencweig M, McLaren C, Beltangady M, Ritter J, Canetta R, Schacter L, Kelley S, Nicaise C, Smaldone L, Dunkle L, et al.

Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S570-5.PMID: 2166965 [PubMed - indexed for MEDLINE]Related articles

Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay.

Schroyens W, Dodion P, Rozencweig M.

J Cancer Res Clin Oncol. 1990;116(4):392-6.PMID: 2202731 [PubMed - indexed for MEDLINE]Related articles

Phase II study of tallysomycin S10b in patients with advanced colorectal cancer.

Nicaise C, Ajani J, Goudeau P, Rozencweig M, Levin B, Krakoff I.

Cancer Chemother Pharmacol. 1990;26(3):221-2.PMID: 1694112 [PubMed - indexed for MEDLINE]Related articles

Resistance to platinum compounds: mechanisms and beyond.

Kelley SL, Rozencweig M.

Eur J Cancer Clin Oncol. 1989 Aug;25(8):1135-40. Review. No abstract available. PMID: 2670584 [PubMed - indexed for MEDLINE]Related articles

Megestrol acetate: clinical experience.

Schacter L, Rozencweig M, Canetta R, Kelley S, Nicaise C, Smaldone L.

Cancer Treat Rev. 1989 Mar;16(1):49-63. Review.PMID: 2471590 [PubMed - indexed for MEDLINE]Related articles

Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative Group.

Verschraegen CF, Kleeberg UR, Mulder J, Rumke P, Truchetet F, Czarnetzki B, Rozencweig M, Thomas D, Suciu S.

Cancer. 1988 Sep 15;62(6):1061-5.PMID: 3409184 [PubMed - indexed for MEDLINE]Related articles

Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assay.

Schroyens WA, Meeker JB, Dodion P, Stryckmans PA, Rozencweig M.

Eur J Cancer Clin Oncol. 1988 Aug;24(8):1309-12.PMID: 3053206 [PubMed - indexed for MEDLINE]Related articles

Carboplatin: current status and future prospects.

Canetta R, Bragman K, Smaldone L, Rozencweig M.

Cancer Treat Rev. 1988 Jun;15 Suppl B:17-32. Review. No abstract available. PMID: 2841021 [PubMed - indexed for MEDLINE]Related articles

The EORTC Clonogenic Assay Screening Study Group (CASSG) program.

Aapro MS, Eliason JF, Herman C, Uitendaal M, Rozencweig M.

Prog Clin Biol Res. 1988;276:255-64. No abstract available. PMID: 3174680 [PubMed - indexed for MEDLINE]Related articles

Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial.

Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M.

Cancer Chemother Pharmacol. 1988;22(4):316-20.PMID: 3048762 [PubMed - indexed for MEDLINE]Related articles

Validation of the clinical predictive values of the in vitro phase II clonogenic assay in cancer of the breast and ovary.

Staquet M, Brown BW Jr, Rozencweig M, Van Muylder E, Dodion P, Sanders C.

Am J Clin Oncol. 1987 Dec;10(6):485-90.PMID: 3687834 [PubMed - indexed for MEDLINE]Related articles

Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitro.

Dodion P, Sanders C, Rombaut W, Mattelaer MA, Rozencweig M, Stryckmans P, Kenis Y.

Eur J Cancer Clin Oncol. 1987 Dec;23(12):1909-14.PMID: 3481336 [PubMed - indexed for MEDLINE]Related articles

Sensitivity of normal human bone marrow myeloid progenitor cells to anthracycline, cisplatin, anthracene and flavone acetic acid derivatives, and its relevance for the prediction of human plasma concentrations of anticancer drugs.

Dodion P, Bron D, Mattelaer MA, Loos M, Delforge A, Rozencweig M, Stryckmans P, Kenis Y.

Eur J Cancer Clin Oncol. 1987 Dec;23(12):1901-8.PMID: 3436354 [PubMed - indexed for MEDLINE]Related articles

Clinical status of carboplatin.

Canetta R, Franks C, Smaldone L, Bragman K, Rozencweig M.

Oncology (Williston Park). 1987 Jul;1(5):61-70. Review.PMID: 3079484 [PubMed - indexed for MEDLINE]Related articles

Phase I study of triglycidylurazol given on a 5-day i.v. schedule.

Nicaise C, Rozencweig M, Crespeigne N, Dodion P, Gerard B, Lambert M, Decoster G, Kenis Y.

Cancer Treat Rep. 1986 May;70(5):599-603.PMID: 3708609 [PubMed - indexed for MEDLINE]Related articles

Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neck.

Dodion P, Cognetti F, van Rymenant M, Dalesio O, Kirkpatrick A, Rozencweig M.

Eur J Cancer Clin Oncol. 1986 Mar;22(3):241-3.PMID: 3709594 [PubMed - indexed for MEDLINE]Related articles

In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assay.

Dodion P, Sanders C, Rombaut W, Rozencweig M, Kitt MM, Kenis Y, Klastersky J.

Eur J Cancer Clin Oncol. 1986 Mar;22(3):245-9.PMID: 2940092 [PubMed - indexed for MEDLINE]Related articles

Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivatives.

Bron D, Dodion P, Rozencweig M, Delforge A, Mattelaer MA, Kenis Y, Stryckmans P.

Invest New Drugs. 1986;4(1):11-6.PMID: 3700036 [PubMed - indexed for MEDLINE]Related articles

Phase I study of oral idarubicin given with a weekly schedule.

Dodion P, Finet C, Crespeigne N, Beer M, Nicaise C, Rozencweig M, Kenis Y.

Invest New Drugs. 1986;4(1):31-8.PMID: 3457779 [PubMed - indexed for MEDLINE]Related articles

Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanoma.

Alberto P, Rozencweig M, Clavel M, Siegenthaler P, Cavalli F, Gundersen S, Bruntsch U, Renard J, Pinedo H.

Cancer Chemother Pharmacol. 1986;16(1):78-9.PMID: 2933177 [PubMed - indexed for MEDLINE]Related articles

Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: reply to a commentary.

Staquet MJ, Byar DP, Green SB, Rozencweig M.

Cancer Treat Rep. 1985 Nov;69(11):1339-40. No abstract available. PMID: 4092201 [PubMed - indexed for MEDLINE]Related articles

Carboplatin: future directions.

Carter SK, Canetta R, Rozencweig M.

Cancer Treat Rev. 1985 Sep;12 Suppl A:145-52. No abstract available. PMID: 3910218 [PubMed - indexed for MEDLINE]Related articles

Carboplatin: the clinical evaluation strategy.

Rozencweig M, Canetta R, Carter SK.

Cancer Treat Rev. 1985 Sep;12 Suppl A:137-44. No abstract available. PMID: 3910217 [PubMed - indexed for MEDLINE]Related articles

Carboplatin: the clinical spectrum to date.

Canetta R, Rozencweig M, Carter SK.

Cancer Treat Rev. 1985 Sep;12 Suppl A:125-36. Review.PMID: 3002623 [PubMed - indexed for MEDLINE]Related articles

Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC Breast Cancer Cooperative Group.

Paridaens R, Clarysse A, Rozencweig M, Rotmensz N, Heuson JC.

Eur J Cancer Clin Oncol. 1985 May;21(5):595-9.PMID: 4040025 [PubMed - indexed for MEDLINE]Related articles

Phase II evaluation of bisantrene in metastatic breast cancer.

Cavalli F, Gerard B, ten Bokkel Huinink W, Clavel M, Rozencweig M.

Cancer Treat Rep. 1985 Mar;69(3):337-8. No abstract available. PMID: 3978661 [PubMed - indexed for MEDLINE]Related articles

Phase II study of ametantrone in a human tumor cloning assay.

Rozencweig M, Sanders C, Rombaut W, Crespeigne N, Kenis Y, Klastersky J.

Eur J Cancer Clin Oncol. 1985 Feb;21(2):195-8.PMID: 3987756 [PubMed - indexed for MEDLINE]Related articles

Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin).

Dodion P, Davis TA, Rozencweig M, Crespeigne N, Kenis Y, Bachur NR.

Invest New Drugs. 1985;3(4):361-8.PMID: 4086243 [PubMed - indexed for MEDLINE]Related articles

Human pharmacokinetics of marcellomycin.

Dodion P, Rozencweig M, Nicaise C, Watthieu M, Tamburini JM, Riggs CE Jr, Bachur NR.

Cancer Chemother Pharmacol. 1985;14(1):42-8.PMID: 3965159 [PubMed - indexed for MEDLINE]Related articles

Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).

Holdener EE, Hansen HH, Høst H, Bruntsch U, Cavalli F, Renard J, Pinedo HM, Rozencweig M.

Invest New Drugs. 1985;3(1):63-6.PMID: 3857219 [PubMed - indexed for MEDLINE]Related articles

Phase I-II evaluation of carminomycin in adults with acute leukemia.

Debusscher L, Malarme M, Bron D, Rozencweig M, Stryckmans P.

Eur J Cancer Clin Oncol. 1985 Jan;21(1):31-4.PMID: 3855751 [PubMed - indexed for MEDLINE]Related articles

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck.

Rozencweig M, Dodion P, Bruntsch U, Gallmeier W, Clavel M, Gignoux B, Cortes Funes H, Cavalli F, Kirkpatrick A, Dalesio O, et al.

Cancer. 1984 Oct 15;54(8):1499-503.PMID: 6206936 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of diaziquone in advanced renal adenocarcinoma.

Hansen M, Gallmeier WM, Vermorken J, Holdener E, Hansen HH, Renard J, Rozencweig M.

Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1055-6. No abstract available. PMID: 6744342 [PubMed - indexed for MEDLINE]Related articles

Predictive tests for the response to cancer chemotherapy: limitations related to the prediction of rare events.

Rozencweig M, Staquet M.

Cancer Treat Rep. 1984 Apr;68(4):611-3.PMID: 6713417 [PubMed - indexed for MEDLINE]Related articles

Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.

Rozencweig M, ten Bokkel Huinink W, Cavalli F, Bruntsch U, Dombernowsky P, Høst H, Bramwell V, Renard G, Van Glabbeke M, Decoster G.

J Clin Oncol. 1984 Apr;2(4):275-81.PMID: 6584561 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung.

Joss RA, Hansen HH, Hansen M, Renard J, Rozencweig M.

Eur J Cancer Clin Oncol. 1984 Apr;20(4):495-9.PMID: 6327315 [PubMed - indexed for MEDLINE]Related articles

[Clonogenic cultures of human tumors. Potentials and difficulties]

Rozencweig M, Sanders C, Rombaut W, Kenis Y, Klastersky J, Decoster G.

Rev Med Liege. 1984 Feb 1;39(3):134-7. French. No abstract available. PMID: 6718867 [PubMed - indexed for MEDLINE]Related articles

Phase II study of 9-hydroxy-2N-methylellipticinium acetate.

Clarysse A, Brugarolas A, Siegenthaler P, Abele R, Cavalli F, de Jager R, Renard G, Rozencweig M, Hansen HH.

Eur J Cancer Clin Oncol. 1984 Feb;20(2):243-7.PMID: 6538489 [PubMed - indexed for MEDLINE]Related articles

Phase II study of carminomycin in a human tumor cloning assay.

Rozencweig M, Sanders C, Rombaut W, Crespeigne N, Decoster G, Kenis Y, Klastersky J.

Invest New Drugs. 1984;2(3):267-70.PMID: 6511232 [PubMed - indexed for MEDLINE]Related articles

In vitro growth of human malignancies in a cloning assay.

Rozencweig M, Hofmann V, Sanders C, Rombaut W, Früh U, Martz G.

Recent Results Cancer Res. 1984;94:1-7. No abstract available. PMID: 6494573 [PubMed - indexed for MEDLINE]Related articles

Predictive tests and infrequent events in cancer chemotherapy.

Rozencweig M, Staquet M.

Recent Results Cancer Res. 1984;94:174-83. No abstract available. PMID: 6387832 [PubMed - indexed for MEDLINE]Related articles